Comparisons between global and focal brain atrophy rates in normal aging and Alzheimer disease: Boundary Shift Integral versus tracing of the entorhinal cortex and hippocampus - PubMed (original) (raw)

Comparative Study

. 2004 Oct-Dec;18(4):196-201.

Linda Chao, John Kornak, An-Tao Du, Valerie Cardenas, Diana Truran, William Jagust, Helena Chui, Bruce Miller, Kristine Yaffe, Norbert Schuff, Michael Weiner

Affiliations

Comparative Study

Comparisons between global and focal brain atrophy rates in normal aging and Alzheimer disease: Boundary Shift Integral versus tracing of the entorhinal cortex and hippocampus

Frank Ezekiel et al. Alzheimer Dis Assoc Disord. 2004 Oct-Dec.

Abstract

The objectives of this study were to (1) compare atrophy rates associated with normal aging and Alzheimer disease (AD) using the semi-automated Boundary Shift Integral (BSI) method and manual tracing of the entorhinal cortex (ERC) and hippocampus and (2) calculate power of BSI vs. ERC and hippocampal volume changes for clinical trials in AD. We quantified whole brain and ventricular BSI atrophy rates and ERC and hippocampal atrophy rates from longitudinal MRI data in 20 AD patients and 22 age-matched healthy controls. All methods revealed significant brain atrophy in controls and AD patients. AD patients had approximately 2.5 times greater whole brain BSI atrophy rates and more than 5 times greater ERC and hippocampal atrophy rates than controls. ERC and hippocampal atrophy rates were higher in both groups than whole brain BSI atrophy rates, but lower than ventricular BSI atrophy rates. Effect size and power calculations suggest that ERC and hippocampal measurements may be more sensitive than ventricular or whole brain BSI for detecting AD progression and the potential effects of disease modifying agents. Logistic regression analysis revealed that combined rates of ERC and ventricular BSI were the best explanatory variables for classifying AD from controls.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Katzman R, Fox P. The World-Wide Impact of Dementia. Projections of Prevalence and Costs. In: Mayeaux R, Christen Y, editors. Epidemiology of Alzheimer’s Disease: From Gene to Prevention. Berlin: Springer-Verlag; 1999. pp. 1–17.
    1. Braak H, Braak E. Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging. 1995;16:271–278. - PubMed
    1. Seab JP, Jagust WJ, Wong ST, et al. Quantitative NMR measurements of hippocampal atrophy in Alzheimer’s disease. Magn Reson Med. 1988;8:200–208. - PubMed
    1. Insausti R, Juottonen K, Soininen H, et al. MR volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices. Am J Neuroradiol. 1998;19:659–671. - PMC - PubMed
    1. Jack CR, Petersen RC, O’Brien PC, et al. MR-based hippocampal volumetry in the diagnosis of Alzheimer’s disease. Neurology. 1992;42:183–188. - PubMed

Publication types

MeSH terms

Grants and funding

LinkOut - more resources